Everspin Technologies Inc. (MRAM) · Oct 28, 2026 · Earnings
In line — Revenue $20.65M vs ~$20.08M consensus; non-GAAP EPS $0.12 vs ~$0.12–$0.13
Everspin’s third-quarter earnings brought a revenue beat and solid adjusted profit, but litigation and regulatory charges overwhelmed GAAP results.
Everspin is trying to scale MRAM beyond its established industrial base into data centers, medical, energy-management and other mission-critical applications, while expanding manufacturing capacity and advancing higher-density and CXL-connected products. The core growth story is working: Third-quarter revenue reached $20.65 million, up 47% year over year and 10% sequentially, modestly above published expectations of roughly $20.1 million. Product sales rose to $16.95 million from $12.69 million, while licensing, royalty, engineering-services and other revenue increased to $3.70 million from $1.37 million (Income Statement). The company said growth was led by Industrial Automation, Data Center, Medical and Energy Management. 〔0〕
| Metric | Q3 2026 | Comparison / expectation |
|---|---|---|
| Revenue | $20.65M | $14.06M year ago; ~$20.08M consensus |
| Gross margin | 51.4% GAAP / 52.1% non-GAAP | 53.9% / 54.7% in Q2 2026 |
| GAAP EPS | $(0.29) | $0.00 year ago; published estimates were around $(0.04) |
| Non-GAAP EPS | $0.12 | $0.06 year ago; roughly in line with ~$0.12–$0.13 consensus |
| Q4 revenue guidance | $21.5M–$22.5M | Versus $20.65M in Q3 |
The adjusted operating engine improved, but headline profitability deteriorated sharply: Non-GAAP operating income was $2.30 million, or an 11.2% margin, versus a $0.14 million loss a year ago and $2.07 million in Q2. That supports the view that the revenue growth is translating into underlying operating profit. But GAAP operating expenses more than doubled to $18.54 million, including $6.0 million of litigation costs and a $2.7 million regulatory provision, producing a $7.93 million operating loss and a $7.18 million net loss.
The quarter advances the business, but does not cleanly remove the overhang: Cash remained substantial at $43.0 million, yet nine-month operating cash flow fell to $1.6 million from $7.3 million a year earlier while capital spending rose to $8.6 million (Cash Flow statement). The filing also shows common shares outstanding increased to 24.4 million from 23.0 million at year-end (Balance Sheet), reflecting additional equity issuance and some dilution while the company funds expansion. The Q4 revenue outlook of $21.5 million to $22.5 million points to continued momentum, but the projected GAAP loss of $0.13 to $0.08 per share confirms that legal and regulatory costs remain material.
Bottom line: This was a solid operating quarter beneath the surface—revenue beat expectations and adjusted profitability improved—but the legal and regulatory charges make the reported result mixed rather than cleanly positive. The business is progressing; the main unresolved question is how long the exceptional cost burden persists.
Q4 results and litigation-cost trajectory
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!